TY - STD TI - PEPFAR. PEPFAR 2020 Country Operational Plan Guidance for all PEPFAR Countries. 2019. ID - ref1 ER - TY - STD TI - PEPFAR 3.0: Controlling the epidemic: Delivering on the promise of an AIDS-free generation [press release]. 2014. ID - ref2 ER - TY - STD TI - PEPFAR Strategy for accelerating HIV/AIDS epidemic control (2017–2020) [press release]. 2017. ID - ref3 ER - TY - BOOK PY - 2017 DA - 2017// TI - Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017 PB - World Health Organization CY - Geneva ID - ref4 ER - TY - STD TI - Global HIV & AIDS statistics 2019 fact sheet [press release]. 2019. ID - ref5 ER - TY - JOUR AU - Egger, M. AU - May, M. AU - Chene, G. AU - Phillips, A. N. AU - Ledergerber, B. AU - Dabis, F. PY - 2002 DA - 2002// TI - Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)09411-4 DO - 10.1016/S0140-6736(02)09411-4 ID - Egger2002 ER - TY - JOUR AU - Walker, A. S. AU - Prendergast, A. J. AU - Mugyenyi, P. AU - Munderi, P. AU - Hakim, J. AU - Kekitiinwa, A. PY - 2012 DA - 2012// TI - Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe JO - Clin Infect Dis VL - 55 UR - https://doi.org/10.1093/cid/cis797 DO - 10.1093/cid/cis797 ID - Walker2012 ER - TY - JOUR AU - Waldrop, G. AU - Doherty, M. AU - Vitoria, M. AU - Ford, N. PY - 2016 DA - 2016// TI - Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy JO - Trop Med Int Health VL - 21 UR - https://doi.org/10.1111/tmi.12746 DO - 10.1111/tmi.12746 ID - Waldrop2016 ER - TY - JOUR AU - Ford, N. AU - Shubber, Z. AU - Meintjes, G. AU - Grinsztejn, B. AU - Eholie, S. AU - Mills, E. J. PY - 2015 DA - 2015// TI - Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis JO - Lancet HIV. VL - 2 UR - https://doi.org/10.1016/S2352-3018(15)00137-X DO - 10.1016/S2352-3018(15)00137-X ID - Ford2015 ER - TY - JOUR AU - Ford, N. AU - Doherty, M. PY - 2017 DA - 2017// TI - The enduring challenge of advanced HIV infection JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMe1707598 DO - 10.1056/NEJMe1707598 ID - Ford2017 ER - TY - JOUR AU - Carmona, S. AU - Bor, J. AU - Nattey, C. AU - Maughan-Brown, B. AU - Maskew, M. AU - Fox, M. P. PY - 2018 DA - 2018// TI - Persistent high burden of advanced HIV disease among patients seeking care in South Africa’s National HIV Program: data from a Nationwide Laboratory Cohort JO - Clin Infect Dis. VL - 66 UR - https://doi.org/10.1093/cid/ciy045 DO - 10.1093/cid/ciy045 ID - Carmona2018 ER - TY - STD TI - PEPFAR. PEPFAR 2019 Country operational plan guidance for all PEPFAR Countries. 2019. ID - ref12 ER - TY - JOUR AU - Post, F. A. AU - Szubert, A. J. AU - Prendergast, A. J. AU - Johnston, V. AU - Lyall, H. AU - Fitzgerald, F. PY - 2018 DA - 2018// TI - Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY Trial JO - Clin Infect Dis VL - 66 UR - https://doi.org/10.1093/cid/cix1141 DO - 10.1093/cid/cix1141 ID - Post2018 ER - TY - BOOK PY - 2019 DA - 2019// TI - Global tuberculosis report 2019 PB - World Health Organization CY - Geneva ID - ref14 ER - TY - JOUR AU - Gupta, R. K. AU - Lucas, S. B. AU - Fielding, K. L. AU - Lawn, S. D. PY - 2015 DA - 2015// TI - Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis JO - AIDS. VL - 29 UR - https://doi.org/10.1097/QAD.0000000000000802 DO - 10.1097/QAD.0000000000000802 ID - Gupta2015 ER - TY - JOUR AU - Badje, A. AU - Moh, R. AU - Gabillard, D. AU - Guehi, C. AU - Kabran, M. AU - Ntakpe, J. B. PY - 2017 DA - 2017// TI - Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial JO - Lancet Glob Health. VL - 5 UR - https://doi.org/10.1016/S2214-109X(17)30372-8 DO - 10.1016/S2214-109X(17)30372-8 ID - Badje2017 ER - TY - JOUR AU - Rajasingham, R. AU - Smith, R. M. AU - Park, B. J. AU - Jarvis, J. N. AU - Govender, N. P. AU - Chiller, T. M. PY - 2017 DA - 2017// TI - Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis JO - Lancet Infect Dis. VL - 17 UR - https://doi.org/10.1016/S1473-3099(17)30243-8 DO - 10.1016/S1473-3099(17)30243-8 ID - Rajasingham2017 ER - TY - JOUR AU - Ford, N. AU - Shubber, Z. AU - Jarvis, J. N. AU - Chiller, T. AU - Greene, G. AU - Migone, C. PY - 2018 DA - 2018// TI - CD4 cell count threshold for cryptococcal antigen screening of HIV-infected individuals: a systematic review and meta-analysis JO - Clin Infect Dis VL - 66 UR - https://doi.org/10.1093/cid/cix1143 DO - 10.1093/cid/cix1143 ID - Ford2018 ER - TY - JOUR AU - Prabhu, S. AU - Harwell, J. I. AU - Kumarasamy, N. PY - 2019 DA - 2019// TI - Advanced HIV: diagnosis, treatment, and prevention JO - Lancet HIV. VL - 6 UR - https://doi.org/10.1016/S2352-3018(19)30189-4 DO - 10.1016/S2352-3018(19)30189-4 ID - Prabhu2019 ER - TY - JOUR AU - O’Connor, J. AU - Vjecha, M. J. AU - Phillips, A. N. AU - Angus, B. AU - Cooper, D. AU - Grinsztejn, B. PY - 2017 DA - 2017// TI - Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per muL: secondary outcome results from a randomised controlled trial JO - Lancet HIV. VL - 4 UR - https://doi.org/10.1016/S2352-3018(16)30216-8 DO - 10.1016/S2352-3018(16)30216-8 ID - O’Connor2017 ER - TY - JOUR AU - Anglaret, X. AU - Eholie, S. P. PY - 2017 DA - 2017// TI - Severe bacterial infections: overlooked opportunistic diseases JO - Lancet HIV. VL - 4 UR - https://doi.org/10.1016/S2352-3018(16)30213-2 DO - 10.1016/S2352-3018(16)30213-2 ID - Anglaret2017 ER - TY - JOUR AU - Munthali, C. AU - Taegtmeyer, M. AU - Garner, P. G. AU - Lalloo, D. G. AU - Squire, S. B. AU - Corbett, E. L. PY - 2014 DA - 2014// TI - Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis JO - J Int AIDS Soc. VL - 17 UR - https://doi.org/10.7448/IAS.17.1.18932 DO - 10.7448/IAS.17.1.18932 ID - Munthali2014 ER - TY - JOUR AU - Hakim, J. AU - Musiime, V. AU - Szubert, A. J. AU - Mallewa, J. AU - Siika, A. AU - Agutu, C. PY - 2017 DA - 2017// TI - Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1615822 DO - 10.1056/NEJMoa1615822 ID - Hakim2017 ER - TY - JOUR AU - Walmsley, S. L. AU - Antela, A. AU - Clumeck, N. AU - Duiculescu, D. AU - Eberhard, A. AU - Gutierrez, F. PY - 2013 DA - 2013// TI - Dolutegravir plus abacavir–lamivudine for the treatment of HIV-1 infection JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1215541 DO - 10.1056/NEJMoa1215541 ID - Walmsley2013 ER - TY - JOUR AU - Clotet, B. AU - Feinberg, J. AU - Lunzen, J. AU - Khuong-Josses, M. A. AU - Antinori, A. AU - Dumitru, I. PY - 2014 DA - 2014// TI - Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study JO - Lancet VL - 383 UR - https://doi.org/10.1016/S0140-6736(14)60084-2 DO - 10.1016/S0140-6736(14)60084-2 ID - Clotet2014 ER - TY - JOUR AU - Dutertre, M. AU - Cuzin, L. AU - Demonchy, E. AU - Pugliese, P. AU - Joly, V. AU - Valantin, M. A. PY - 2017 DA - 2017// TI - Initiation of antiretroviral therapy containing integrase inhibitors increases the risk of IRIS requiring hospitalization JO - J Acquir Immune Defic Syndr VL - 76 UR - https://doi.org/10.1097/QAI.0000000000001397 DO - 10.1097/QAI.0000000000001397 ID - Dutertre2017 ER - TY - JOUR AU - Sterling, T. R. AU - Scott, N. A. AU - Miro, J. M. AU - Calvet, G. AU - Rosa, A. AU - Infante, R. PY - 2016 DA - 2016// TI - Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons JO - AIDS. VL - 30 UR - https://doi.org/10.1097/QAD.0000000000001098 DO - 10.1097/QAD.0000000000001098 ID - Sterling2016 ER - TY - JOUR AU - Swindells, S. AU - Ramchandani, R. AU - Gupta, A. AU - Benson, C. A. AU - Leon-Cruz, J. AU - Mwelase, N. PY - 2019 DA - 2019// TI - One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis JO - N Engl J Med VL - 380 UR - https://doi.org/10.1056/NEJMoa1806808 DO - 10.1056/NEJMoa1806808 ID - Swindells2019 ER - TY - JOUR AU - Mfinanga, S. AU - Chanda, D. AU - Kivuyo, S. L. AU - Guinness, L. AU - Bottomley, C. AU - Simms, V. PY - 2015 DA - 2015// TI - Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(15)60164-7 DO - 10.1016/S0140-6736(15)60164-7 ID - Mfinanga2015 ER - TY - JOUR AU - Loyse, A. AU - Burry, J. AU - Cohn, J. AU - Ford, N. AU - Chiller, T. AU - Ribeiro, I. PY - 2019 DA - 2019// TI - Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries JO - Lancet Infect Dis. VL - 19 UR - https://doi.org/10.1016/S1473-3099(18)30493-6 DO - 10.1016/S1473-3099(18)30493-6 ID - Loyse2019 ER - TY - JOUR AU - Pathmanathan, I. AU - Date, A. AU - Coggin, W. L. AU - Nkengasong, J. AU - Piatek, A. S. AU - Alexander, H. PY - 2017 DA - 2017// TI - Rolling out Xpert((R)) MTB/RIF for TB detection in HIV-infected populations: an opportunity for systems strengthening JO - Afr J Lab Med. VL - 6 UR - https://doi.org/10.4102/ajlm.v6i2.460 DO - 10.4102/ajlm.v6i2.460 ID - Pathmanathan2017 ER - TY - BOOK PY - 2019 DA - 2019// TI - Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV, Policy update (2019) PB - World Health Organization CY - Geneva ID - ref32 ER - TY - JOUR AU - Broger, T. AU - Sossen, B. AU - Toit, E. AU - Kerkhoff, A. D. AU - Schutz, C. AU - Ivanova Reipold, E. PY - 2019 DA - 2019// TI - Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study JO - Lancet Infect Dis. VL - 19 UR - https://doi.org/10.1016/S1473-3099(19)30001-5 DO - 10.1016/S1473-3099(19)30001-5 ID - Broger2019 ER - TY - JOUR AU - Moore, C. C. AU - Jacob, S. T. AU - Banura, P. AU - Zhang, J. AU - Stroup, S. AU - Boulware, D. R. PY - 2019 DA - 2019// TI - Etiology of sepsis in Uganda using a quantitative polymerase chain reaction-based TaqMan array card JO - Clin Infect Dis. VL - 68 UR - https://doi.org/10.1093/cid/ciy472 DO - 10.1093/cid/ciy472 ID - Moore2019 ER - TY - JOUR AU - Siddiqi, O. K. AU - Ghebremichael, M. AU - Dang, X. AU - Atadzhanov, M. AU - Kaonga, P. AU - Khoury, M. N. PY - 2014 DA - 2014// TI - Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults JO - Clin Infect Dis VL - 58 UR - https://doi.org/10.1093/cid/ciu191 DO - 10.1093/cid/ciu191 ID - Siddiqi2014 ER - TY - JOUR AU - Kozel, T. R. AU - Burnham-Marusich, A. R. PY - 2017 DA - 2017// TI - Point-of-care testing for infectious diseases: past, present, and future JO - J Clin Microbiol VL - 55 UR - https://doi.org/10.1128/JCM.00476-17 DO - 10.1128/JCM.00476-17 ID - Kozel2017 ER - TY - BOOK PY - 2019 DA - 2019// TI - WHO consolidated guidelines on drug-resistant tuberculosis treatment PB - World Health Organization CY - Geneva ID - ref37 ER - TY - JOUR AU - Molloy, S. F. AU - Kanyama, C. AU - Heyderman, R. S. AU - Loyse, A. AU - Kouanfack, C. AU - Chanda, D. PY - 2018 DA - 2018// TI - Antifungal combinations for treatment of Cryptococcal meningitis in Africa JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1710922 DO - 10.1056/NEJMoa1710922 ID - Molloy2018 ER - TY - JOUR AU - Zar, H. J. AU - Madhi, S. A. AU - Aston, S. J. AU - Gordon, S. B. PY - 2013 DA - 2013// TI - Pneumonia in low and middle income countries: progress and challenges JO - Thorax VL - 68 UR - https://doi.org/10.1136/thoraxjnl-2013-204247 DO - 10.1136/thoraxjnl-2013-204247 ID - Zar2013 ER - TY - JOUR AU - Walusimbi, S. AU - Semitala, F. AU - Bwanga, F. AU - Haile, M. AU - Costa, A. AU - Davis, L. PY - 2016 DA - 2016// TI - Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study JO - Pan Afr Med J. VL - 23 ID - Walusimbi2016 ER - TY - STD TI - PEPFAR. Monitoring, evaluation, and reporting indicator reference guide (MER 2.0), Version 2.3. 2018. ID - ref41 ER - TY - STD TI - PEPFAR. Monitoring, evaluation, and reporting indicator reference guide (MER 2.0), Version 2.4. 2019. ID - ref42 ER - TY - JOUR AU - Vizcarra, P. AU - Perez-Elias, M. J. AU - Quereda, C. AU - Moreno, A. AU - Vivancos, M. J. AU - Dronda, F. PY - 2020 DA - 2020// TI - Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort JO - Lancet HIV. UR - https://doi.org/10.1016/S2352-3018(20)30164-8 DO - 10.1016/S2352-3018(20)30164-8 ID - Vizcarra2020 ER - TY - JOUR AU - Altuntas Aydin, O. AU - Kumbasar Karaosmanoglu, H. AU - Kart Yasar, K. PY - 2020 DA - 2020// TI - HIV/SARS-CoV-2 coinfected patients in Istanbul JO - J Med Virol. UR - https://doi.org/10.1002/jmv.25955 DO - 10.1002/jmv.25955 ID - Altuntas Aydin2020 ER -